The literature findings tell us that the classical pathway activation at a low level is a relatively frequent, albeit a probably non-harmful phenomenon in B-CLL, mediated by the formation of IgG hexamers and binding to alpha-2 macroglobulin [15,16,17]. This evidence concerns the gene A2M and B-cell chronic lymphocytic leukemia.